SITUATION REPORT YELLOW FEVER 15 JULY 2016 SUMMARY

Similar documents
SITUATION REPORT YELLOW FEVER 8 JULY 2016 SUMMARY

SITUATION REPORT YELLOW FEVER 28 JULY 2016 SUMMARY

SITUATION REPORT YELLOW FEVER 16 JUNE 2016 SUMMARY

SITUATION REPORT YELLOW FEVER 5 AUGUST 2016 SUMMARY

SITUATION REPORT YELLOW FEVER 26 MAY 2016 SUMMARY

SITUATION REPORT YELLOW FEVER 20 MAY 2016 SUMMARY

SITUATION REPORT YELLOW FEVER 23 SEPTEMBER 2016 KEY UPDATES ANALYSIS. EPIDEMIOLOGICAL SITUATION Angola

YELLOW FEVER UPDATE. DPGH Meeting Dr. Grace Saguti NPO/DPC 13 July 2016

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

CAA Meeting COMMUNICABLE DISEASE CONTROL. 20 July 2016

YELLOW FEVER OUTBREAK IN ANGOLA INCIDENT MANAGEMENT

Outbreaks and Emergencies Bulletin

YELLOW FEVER OUTBREAK IN ANGOLA INCIDENT MANAGEMENT

YELLOW FEVER OUTBREAK IN ANGOLA INCIDENT MANAGEMENT

YELLOW FEVER OUTBREAK IN ANGOLA INCIDENT MANAGEMENT

YELLOW FEVER OUTBREAK IN ANGOLA INCIDENT MANAGEMENT

SYMPOSIUM 2: COMMUNICABLE DISEASES

Outbreaks of yellow fever in Angola, Democratic Republic of Congo and Uganda

Epidemiology and Response Datapack

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

YELLOW FEVER STRATEGIC RESPONSE PLAN JUNE-AUGUST 2016

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 4 Issue 3, 23 May 2014

IMMUNIZATION VACCINES & EMERGENCIES

RESIDENT / HUMANITARIAN COORDINATOR REPORT ON THE USE OF CERF FUNDS ANGOLA RAPID RESPONSE YELLOW FEVER 2016

RVF Outbreak Update - Niger

FRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION. Report of the Secretariat

YELLOW FEVER. Strategic Response Framework. World Health Organization JUNE AUGUST 2016 JUNE 2016

Media centre Statement on the 7th IHR Emergency Committee meeting regarding the international spread of poliovirus

YELLOW FEVER OUTBREAK IN ANGOLA INCIDENT MANAGEMENT

EBOLA VIRUS DISEASE. Democratic Republic of Congo. External Situation Report 1. Credit : B.Sensasi / WHO Uganda-2007

European Centre for Disease Prevention and Control. Zika virus disease

Wild Poliovirus Weekly Update

Yellow fever laboratory capacity on-site assessments in Africa: preliminary findings

Committee to Advise on Tropical Medicine and Travel - CATMAT. Yellow Fever Update 2018 Manitoba Travel Health Conference Yen-Giang Bui, MD, DTMH

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

Yellow fever. Key facts

EBOLA VIRUS DISEASE. Page 1

GAVI S CONTINUED ROLE IN YELLOW FEVER CONTROL

Guide on Access to the Yellow Fever ICG Stockpile. Emergency Campaigns. International Coordinating Group on Vaccine. Geneva, Switzerland 2012

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA

Global and Regional update on Polio Eradication Activities. Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 6, 13 September 2012

EBOLA VIRUS DISEASE. Democratic Republic of Congo. External Situation Report 2. Credit : B.Sensasi / WHO Uganda-2007

EBOLA VIRUS DISEASE. Page 1

Global Measles and Rubella Update November 2018

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 3, April 30, 2012

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005

PUBLIC HEALTH EMERGENCIES AND RESPONSES IN WEST AND CENTRAL AFRICA

Measles and rubella monitoring January 2015

Global Measles and Rubella Update. April 2018

Poliovirus : éradication pour les prochaines JNI?

II. Progress and Results

Yellow Fever Vaccine: Current Outlook. UNICEF Supply Division

Global Measles and Rubella Update October 2018

GLOBAL HEALTH & UNDERSERVED POPULATIONS PROGRAM. Yellow Fever. Wednesday, May 25, 2016

IMMUNIZATION VACCINE DEVELOPMENT

Yellow Fever Vaccine

VPD in Mediterranean Basin and Black Sea: the Polio case

ANGOLA El Niño Drought Humanitarian Situation Report January - June 2017

EBOLA VIRUS DISEASE. Democratic Republic of the Congo. External Situation Report 28. Date of information: 30 June

POLIO ERADICATION IN THE AFRICAN REGION: PROGRESS REPORT. Information document EXECUTIVE SUMMARY

EBOLA VIRUS DISEASE. Page 1


CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN

EBOLA VIRUS DISEASE. Democratic Republic of the Congo. External Situation Report 21. Date of information: 05 June

ANGOLA. Summary of UNICEF Emergency Needs for 2009*

EBOLA VIRUS DISEASE. Democratic Republic of the Congo. External Situation Report 28. WHO Health Emergencies Programme. Page 1

EBOLA VIRUS DISEASE. Page 1

BULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January 2006 ISSN

EBOLA VIRUS DISEASE. Page 1

EBOLA VIRUS DISEASE. Democratic Republic of Congo. External Situation Report 2 Date of issue: 16 May Situation update

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 4, 26 May 2012

EBOLA VIRUS DISEASE. Democratic Republic of the Congo. External Situation Report 22. Date of information: 08 June

EBOLA VIRUS DISEASE. Democratic Republic of the Congo. External Situation Report 30. WHO Health Emergencies Programme. Page 1

RAM U S. D E P A R T M E N T O F H E A L T H. E D U C A T IO N. AND W E LF A R E. J u l y 1970

Figure 1: Suspected and confirmed Zika virus cases reported by countries and territories in the Americas, by epidemiological week (EW)

EBOLA VIRUS DISEASE. Democratic Republic of Congo. External Situation Report 6

EBOLA SITUATION REPORT

Outbreaks and Emergencies Bulletin

EBOLA SITUATION REPORT

Report to the Board 7-8 December 2016

EBOLA VIRUS DISEASE. Democratic Republic of the Congo. External Situation Report 29. WHO Health Emergencies Programme. Page 1

EBOLA SITUATION REPORT

Update on Progress and Challenges in Achieving Measles and Rubella Targets

EBOLA VIRUS DISEASE. Democratic Republic of the Congo. External Situation Report 25. Date of information: 19 June

'Conflict in new Ebola zone of DR Congo exacerbates complexity of response' Dimanche, 05 Août :22 - Mis à jour Dimanche, 05 Août :24

Eliminate Yellow Fever Epidemics (EYE)

EVIDENCE-TO-DECISION TABLE FOR FRACTIONAL DOSE YELLOW FEVER VACCINATION. Yellow fever vaccine: WHO position on the use of fractional doses, June 2017

EBOLA VIRUS DISEASE. Democratic Republic of the Congo. External Situation Report 36. WHO Health Emergencies Programme. Page 1

Zika Outbreak Discussion

Emerging TTIs How Singapore secure its blood supply

EBOLA VIRUS DISEASE. Democratic Republic of the Congo. External Situation Report 20. Date of information: 02 June

Zika Outbreak: a PHEIC & Zika virus preparedness and response ac:vi:es in the African Region. Dr Zabulon Yo, & Dr Anthony Stewart

EBOLA VIRUS DISEASE. Democratic Republic of the Congo. External Situation Report 27. WHO Health Emergencies Programme. Page 1

CONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN

EBOLA VIRUS DISEASE. Democratic Republic of the Congo. External Situation Report 19. Date of information: 01 June

Immunization Multi-Year Plan

CRED Technical Brief: Outbreaks in Fragile States. Yellow Fever in Darfur September December 2012

Epidemiological study of cholera hotspots and epidemiological basins in East and Southern Africa. In-depth report on cholera epidemiology in Angola

1. YELLOW FEVER BACKGROUND 2. YELLOW FEVER IN SOUTH AMERICA

Transcription:

BABAY ZIKA VIRUS SITUATION REPORT YELLOW FEVER 15 JULY 2016 SUMMARY In Angola, as of 8 July 2016 a total of 3625 suspected cases have been reported, of which 876 are confirmed. The total number of reported deaths is 357, of which 117 were reported among confirmed cases. Suspected cases have been reported in all 18 provinces and confirmed cases have been reported in 16 of 18 provinces and 80 of 125 reporting districts. Mass reactive vaccination campaigns first began in Luanda and have now expanded to cover most of the other affected parts of Angola. Recently, the campaigns have focused on border areas. Despite extensive vaccination efforts circulation of the virus persists. Eleven reactive and pre-emptive mass vaccination campaigns are ongoing in several districts in Benguela, Huambo, Huila, Kwanza Norte, Kwanza Sul, Lunda Norte and Uige provinces. Six other mass vaccination campaigns are nearing completion. Mop-up campaigns are being implemented in parts of the provinces of Cunene, Lunda Norte, Uige and Zaire. Other than an increase in the number of suspected cases recently reported, there are no updates regarding the epidemiological situation in the Democratic Republic of The Congo (DRC). For the last three weeks the national laboratory in DRC has been unable to confirm or discard any suspected cases of yellow fever due to technical issues. According to the latest available information (as of 11 July), the total number of notified suspected cases is 1798, with 68 confirmed cases (as of 24 June) and 85 reported deaths. Cases have been reported in 22 health zones in five of 26 provinces. Of the 68 confirmed cases, 59 were imported from Angola, two are sylvatic (not related to the outbreak) and seven are autochthonous. In DRC, surveillance efforts have increased and vaccination campaigns have centred on affected health zones in Kinshasa and Kongo Central. Reactive vaccination campaigns will start on 20 July, in Kisenso health zone in Kinshasa province and in Kahemba, Kajiji and Kisandji health zones in Kwango province. Two additional countries have reported confirmed yellow fever cases imported from Angola: Kenya (two cases) and People s Republic of China (11 cases). These cases highlight the risk of international spread through non-immunised travellers. Seven countries (Brazil, Chad, Colombia, Ghana, Guinea, Peru and Uganda) are currently reporting yellow fever outbreaks or sporadic cases not linked to the Angolan outbreak. 1

Following the advice of the Emergency Committee convened on 19 May 2016, the WHO Director-General decided that urban yellow fever outbreaks in Angola and DRC are serious public health events which warrant intensified national action and enhanced international support. The events do not at this time constitute a Public Health Emergency of International Concern. WHO Strategic Advisory Group of Experts (SAGE) on Immunization reviewed existing evidence that demonstrates that using a fifth of a standard vaccine dose would still provide protection against the disease for at least 12 months and possibly longer. This approach, known as fractional dosing, is under consideration as a short-term measure, in the context of a potential vaccine shortage in emergencies. 1 EPIDEMIOLOGICAL SITUATION Angola From 5 December 2015 to 8 July 2016, the Ministry of Health has reported a total of 3625 suspected cases of which 876 are laboratory confirmed (Table 1). The total number of reported deaths is 357, of which 117 have been reported among confirmed cases. Suspected cases have been reported in all provinces, and confirmed cases have been reported in 16 of 18 provinces (Fig. 2). Confirmed cases have been reported in 80 of 125 reporting districts (Table 2). The epidemic curve (Fig. 1) shows the total number of confirmed and probable cases increased from early 2016 and the number of confirmed cases peaked in weeks 8 to 9 (22 February to 6 March). Surveillance efforts have been strengthened in most provinces. Luanda and Huambo remain the most affected provinces as of 8 July with 1945 cases (487 confirmed) and 591 cases (127 confirmed), respectively (Fig. 3). Benguela province, and in particular the cities of Benguela and Lobito, have become of particular concern. According to reports surveillance in these two areas is insufficient and there are substantial delays in reporting. Local transmission is now reported in 43 districts in 12 provinces (Fig. 3). The confirmed case with the most recent date of symptom onset, 22 June, was reported in Soyo district in Zaire province. The most recently reported confirmed case in Luanda province has symptom onset on 27 May. The majority of cases are among males aged between nine and 19 years. Three countries have reported confirmed yellow fever cases imported from Angola: DRC (59 cases), Kenya (two cases) and People s Republic of China (11 cases). These cases highlight the risk of international spread through non-immunised travellers. 1 http://www.who.int/mediacentre/news/statements/2016/yellow-fever-vaccine/en/ 2

Figure 1. National weekly number of probable and confirmed yellow fever cases in Angola, 5 December 2015 to 8 July 2016 Data provided by Angola yellow fever situation report on 9 July 2016. Data for the last four weeks is incomplete due to lags between onset of symptoms and reporting. 3

Figure 2. Monthly timeline of infected districts in Angola, February 2016 to 8 July 2016 4

Figure 3. Distribution of yellow fever confirmed cases in Angola and Democratic Republic of The Congo Data is as of 8 July for Angola and 28 June for Democratic Republic of The Congo. Democratic Republic of The Congo (DRC) On 22 March 2016, the Ministry of Health of DRC notified WHO of suspected yellow fever cases in connection with Angola. The yellow fever outbreak in DRC was officially declared on 23 April. There are no updates regarding the epidemiological situation in DRC. For the last three weeks the national laboratory in DRC has been unable to confirm or discard any suspected cases of yellow fever due to technical issues. As of 11 July, DRC has reported 1798 suspected and 68 confirmed cases (as of 24 June) with 85 reported deaths (Table 1). Results for at least 300 suspected cases are pending, including one case in Kasai: a province which has not previously reported yellow fever cases. In the past two weeks, most of the suspected cases have been reported from Kinshasa province. The confirmed case with the most recent date of symptom onset, 12 June, was reported in Muanda health zone in Kongo Central province. 5

Of the 68 confirmed cases (as of 24 June), 59 are imported from Angola (reported in Kongo Central, Kinshasa and Kwango provinces), two are sylvatic cases in Northern provinces, and seven are other autochthonous cases. The seven autochthonous cases were reported in Ndjili, Kimbanseke and Kisenso districts (Kinshasa province), in Matadi district (Kongo Central province) and in Kahemba (Kwango province) (Fig. 3). The majority of the cases in DRC are male and they are mainly aged between 20 and 34 years. Table 1: Reported yellow fever cases and deaths in Angola and Democratic Republic of The Congo Angola Democratic Republic of The Congo Cases and deaths Recent week ( 1 Jul 8 Jul) Cumulative (5 Dec 8 Jul) Recent week (25 June 11 Jul) Cumulative (22 Mar 11 Jul) Confirmed cases 1 876 Not available 68 Confirmed deaths Not available 117 Not available Not available Reported cases 73 3625 285 1798 Reported deaths 2 357 Not available 85 Cases and deaths include both autochthonous and imported cases. Data is as of most recent week for which data is available. These numbers are subject to change due to ongoing reclassification, retrospective investigation and availability of laboratory results. Table 2: Geographical distribution of yellow fever cases in Angola and Democratic Republic of The Congo Angola Democratic Republic of The Congo Geographical distribution of cases Recent week Cumulative Recent week Cumulative (1 Jul 8 Jul) (5 Dec 8 Jul) (25 Jun 11 Jul) (1 Jan 11 Jul) Districts/ health zones with confirmed cases 0 80 Not available 22 Districts/ health zones with documented local transmission 0 43 Not available 7* Provinces with confirmed cases 9 16 Not available 5* Provinces with documented local transmission 0 12 Not available 3 Data is as of most recent week for which data is available. These numbers are subject to change due to ongoing reclassification, retrospective investigation and availability of laboratory results. Data for the most recent week represents newly affected districts/ health zones or provinces. *Includes sylvatic cases. Other countries reporting yellow fever transmission Republic of Congo Republic of Congo reported two suspected cases of yellow fever in Bouenza department in May and June 2016. Both cases were vaccinated and have been tested IgM positive for yellow fever due to vaccine immunogenicity. Further investigations and laboratory analysis are ongoing. 6

Guinea Guinea has reported 39 suspected cases since January 2016, including 8 probable cases. Two of these probable cases, tested in the Institute Pasteur Dakar (IPD), were IgM positive for yellow fever. Additional analyses are underway to confirm these two samples by serum neutralization. The last major yellow fever outbreaks in Guinea were reported from 2000 to 2001 in Mamou, Labe, Koubia, Malet and Nzérékoré and in 2005 in Fouta Djalon, Bake, Biffa, Gaul and Kondara. Chad, Ghana and Uganda The situation in these three countries remains stable and there are no changes since last week. Peru In Peru, as of the week ending 19 June, 42 probable and 37 confirmed cases of yellow fever with nine deaths have been reported. Cases were reported from seven departments with most cases reported from Junin department (58 probable and confirmed cases). The transmission cycle is occurring in endemic-enzootic areas with a history of known transmission. There are no updates regarding this event since last week. This event is not linked to the Angolan yellow fever outbreak. Geographical spread to the pacific coast is considered unlikely. Brazil and Colombia The situation in these two countries remains stable and there are no changes since last week. 7

Risk assessment The outbreak in Angola remains of high concern due to: Persistent local transmission despite the fact that approximately 15 million people have been vaccinated; Local transmission has been reported in 12 highly populated provinces including Luanda. The continued extension of the outbreak to new provinces and new districts; High risk of spread to neighbouring countries. As the borders are porous with substantial cross-border social and economic activities, further transmission cannot be excluded. Viraemic travelling patients pose a risk for the establishment of local transmission especially in countries where adequate vectors and susceptible human populations are present; Risk of establishment of local transmission in other provinces where no autochthonous cases are reported; High index of suspicion of ongoing transmission in hard-to-reach areas such as the province of Cabinda; In DRC, the outbreak has spread to three provinces. Given the limited availability of vaccines, the large Angolan community in Kinshasa, the porous border between Angola and DRC, and the presence and the activity of the vector Aedes in the country, the outbreak might extend to other provinces, in particular Kasai, Kasai Central and Lualaba. The virus in Angola and DRC is largely concentrated in main cities; however, there is a high risk of spread and local transmission to other provinces in both countries. In addition, the risk is high for potential spread to bordering countries, especially those classified as low-risk (i.e. Namibia, Zambia) and where the population, travelers and foreign workers are not vaccinated for yellow fever. Some African countries (Chad, Ghana, Guinea, Republic of Congo and Uganda) and some countries in South America (Brazil, Colombia and Peru) have reported cases of yellow fever in 2016. These events are not related to the Angolan outbreak, but there remains a need for vaccines in those countries, which poses additional strain on the limited global yellow fever vaccine stockpile. RESPONSE An Emergency Committee (EC) regarding yellow fever was convened by WHO s Director- General under the International Health Regulations (IHR 2005) on 19 May 2016. Following advice from the EC, the Director-General decided that the urban yellow fever outbreaks in Angola and DRC are serious public health events which warrant intensified national action and enhanced international support. The events do not at this time constitute a Public Health Emergency of International Concern 2. Information on the current outbreak continues to be updated on the WHO website 3. 2 http://www.who.int/mediacentre/news/statements/2016/ec-yellow-fever/en/ 3 http://www.who.int/features/qa/yellow-fever/en/ 8

The WHO Strategic Advisory Group of Experts (SAGE) on Immunization reviewed existing evidence that demonstrates that using a fifth of a standard vaccine dose would provide protection against yellow fever for at least 12 months and possibly much longer 4. This approach, known as fractional dosing, is under consideration as a short-term measure, in the context of a potential vaccine shortage for use in emergencies. As of 5 July 2016, vaccination coverage has reached approximately 15 million people in Angola, 3 million people in DRC and 1.3 million people in Uganda (Table 3). The number of vaccines currently available for the emergency response is 8.1 million through the ICG (Table 4). The amount of doses already allocated to respond to the outbreak is not included in this number. In DRC, reactive vaccination campaigns started on 2 July, in Kisenso health zone in Kinshasa province and in Kahemba, Kajiji and Kisandji health zones in Kwango province. Table 3. Vaccination coverage in Angola, the Democratic Republic of The Congo (DRC) and Uganda as of 5 July 2016 Country Target areas: Province/Region (District/Health zone) Doses approved (in millions) Delivery date (2016) Luanda (Viana) 1.8 2 & 4 Feb Luanda (all 8 districts) 5.6 8 & 27 Feb, 14 & 25 Mar Angola 6 Apr, 11 May & Benguela, Bie, Huambo, Kwanza Sul 4.3 12 May Benguela, Bie, Cunene, Huila, Kuando Kubango, Kwanza Norte, Kwanza Sul, Namibe, Uige 3.3 1, 11, 21 & 27 Jun Kinshasa, Kongo Central 2.2 13, 17-19 May DRC Kwango province (3 health zones), 1.1 2 Jul Kinshasa (Kisenso) Uganda Masaka, Rukungiri 0.7 3 May Kalangala 0.06 20 May 4 http://www.who.int/mediacentre/news/statements/2016/yellow-fever-vaccine/en/ 9

Table 4. Cumulative number of vaccine doses (millions) available and projected for emergency stockpile Date (as of) Number of vaccine doses available* 5 July 8.1 Cumulative number of vaccine doses projected 31 July 10.3 28 August 13.7 30 September 13.2 31 October 15.2 30 November 14.6 31 December 16.6 *Number of doses available is the current stock minus number of vaccine doses planned to be distributed for emergency response. Numbers are projections and are subject to change. Figure 4. Vaccination population coverage in Angola as of 8 July 2016 10